Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
In real-world patients with mHSPC, a PSA cutoff of 0.2 ng/mL after 6 to 12 months of intensified hormone therapy predicts survival outcomes. An absolute PSA level of 0.2 ng/mL or more at 6 to 12 ...
After years of unexplained fatigue and mood swings, I discovered that what I ate had more power over my hormones than I ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback